Mon panier

ASGR1&ASGR2

ASGR1&ASGR2 Liste de produits

  • Attribut

    Cell (1)

  • Bibliothèque de produits

    En ligne (1)

  • Espèces

    Human (1)

  • Étiquette

    - (1)

  • Marqueur

    - (1)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
Human
HEK293
HEK293/Human ASGR1&ASGR2 Stable Cell Line Ajouter au panier
Quantité totale1
  • 1

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Romiplostim biosimilar (Enzene Biosciences)267639-76-9Phase 3 ClinicalEnzene Biosciences LtdPurpura, Thrombocytopenic, Idiopathic
Details
Romiplostim biosimilar (Intas Pharmaceuticals)Phase 3 ClinicalIntas BiopharmaceuticalsPurpura, Thrombocytopenic, Idiopathic
Details
Romiplostim biosimilar(Generium)GNR-069Phase 3 ClinicalCjsc GeneriumPurpura, Thrombocytopenic, Idiopathic
Details
Recombinant human thrombopoietin(Peking University People's Hospital)Phase 2 ClinicalPeking University People'S HospitalPurpura, Thrombocytopenic, Idiopathic
Details
Recombinant human thrombopoietin mimetics (Shandong Quangang)Phase 2 ClinicalShandong Quangang Pharmaceutical Co LtdPurpura, Thrombocytopenic, Idiopathic
Details
Recombinant human thrombopoietin (CPGJ)Phase 1 ClinicalSunshine GuoJian Pharmaceutical (Shanghai) Co LtdThrombocytopenia
Details
Pegylated thrombopoietin mimetic peptideSF-303; JNJ-26366821; RWJ-800088; PEG-TPOmPhase 1 ClinicalJohnson & Johnson
Details
Romiplostim biosimilar(Geropharma)GP-40141Phase 1 ClinicalGeropharmPurpura, Thrombocytopenic, Idiopathic
Details
SCB-219SCB-219-M; SCB-219; SCB-219MPhase 1 ClinicalPurpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Recombinant human thrombopoietin mimetic peptide-Fc fusion protein (Beijing Tide Pharmaceutical)Phase 1 ClinicalBeijing Tide Pharmaceutical Co LtdThrombocytopenia
Details
PEGylated thrombopoietin (Chongqing Paijin Bio)Phase 1 ClinicalThrombocytopenia
Details
Thrombopoietin agonist (Scripps Research)3D9ClinicalThe Scripps Research Institute IncThrombocytopenia
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Recombinant human thrombopoietin biosimilar (Biolotus)ApprovedBiolotusZypotin-TPOBrazilThrombocytopeniaBiolotus2015-01-01Thrombocytopenia
Details
RomiplostimAMP-2; AMG-531ApprovedAmgen IncRomiplate, NplateUnited StatesThrombocytopenia; Purpura, Thrombocytopenic, IdiopathicAmgen Inc2008-08-22Bone Marrow Failure Disorders; Carcinoma, Non-Small-Cell Lung; Lymphoma; Lung Neoplasms; Lymphoma, Non-Hodgkin; Purpura, Thrombocytopenic; Thrombocytopenia; Acute Radiation Syndrome; Pancytopenia; Anemia, Aplastic; Solid tumours; Multiple Myeloma; Myelodysplastic Syndromes; Hodgkin Disease; Small Cell Lung Carcinoma; Neoplasms; Hematologic Neoplasms; Ovarian Neoplasms; Purpura, Thrombocytopenic, Idiopathic
Details
LusutrombopagS-888711ApprovedShionogi & Co LtdMulpletaJapanThrombocytopeniaShionogi & Co Ltd2015-09-28Purpura, Thrombocytopenic, Idiopathic; Liver Diseases; Thrombocytopenia
Details
Herombopag OlamineSHR-8735; SHR 8735 olamineApprovedHengqu, 恒曲Mainland ChinaAnemia, Aplastic; ThrombocytopeniaJiangsu Hengrui Medicine Co Ltd2021-06-16Purpura, Thrombocytopenic, Idiopathic; Liver Diseases; Anemia, Aplastic; Breast Neoplasms; Thrombocytopenia; Carcinoma, Non-Small-Cell Lung
Details
Recombinant human thrombopoietin mimetic-fusion protein (Qilu Pharmaceutical)QL-0911ApprovedQilu Pharmaceutical Co LtdMainland ChinaThrombocytopeniaQilu Pharmaceutical Co Ltd2024-04-02Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Eltrombopag DiolamineSB-497115; SB-497115-GR; ETB-115ApprovedGlaxosmithkline PlcRevolade, Promacta/Revolade, 瑞弗兰, レボレード, PromactaUnited StatesPurpura, Thrombocytopenic, IdiopathicNovartis Pharma Ag2008-11-20Osteosarcoma; Delayed Graft Function; Bone Marrow Failure Disorders; Liver Diseases; Leukemia, Megakaryoblastic, Acute; Multiple Myeloma; Hemorrhage; Anemia, Aplastic; Hepatitis B; Leukemia, Basophilic, Acute; Sarcoma; Liver Cirrhosis; Hepatitis C; Primary Myelofibrosis; Leukemia, Myeloid, Chronic-Phase; Thrombocytopenia; Leukemia, Myeloid, Acute; Leukemia, Monocytic, Acute; Hepatitis C, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Catheter-Related Infections; Leukemia, Eosinophilic, Acute; Wiskott-Aldrich Syndrome; Leukemia; Solid tumours; Hematologic Neoplasms; HIV Infections; Leukemia, Myelogenous, Chronic; Bone marrow transplant rejection; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Accelerated Phase; Hematopoietic stem cell transplantation (HSCT); Purpura, Thrombocytopenic, Idiopathic; Metabolic Dysfunction-Associated Steatotic Liver Disease; Purpura; Myelodysplastic Syndromes; Blood Platelet Disorders; Anemia, Diamond-Blackfan; Fanconi Anemia; Leukemia, Myelomonocytic, Acu
Details
Avatrombopag MaleateYM-477; AKR-501; AS-1670542; AKR-501-monomaleate; E-5501ApprovedAstellas Pharma IncDoptelet, 苏可欣United StatesLiver Diseases; ThrombocytopeniaAkarx Inc2018-05-21Drug-Related Side Effects and Adverse Reactions; Purpura, Thrombocytopenic, Idiopathic; Liver Diseases; Anemia, Aplastic; Cardiovascular Diseases; Thrombocytopenia; Lymphoma
Details
Recombinant human thrombopoietinrhTPO (3SBio)ApprovedShenyang Sunshine Pharmaceutical Co Ltd特比奥, Tpiao, 特比澳Mainland ChinaThrombocytopenia; Purpura, Thrombocytopenic, IdiopathicShenyang Sunshine Pharmaceutical Co Ltd2005-03-10Purpura, Thrombocytopenic, Idiopathic; Leukemia; Neutropenia; Plasmacytoma; Sepsis; Liver Cirrhosis; Multiple Myeloma; Liver Diseases; Breast Neoplasms; Thrombocytopenia; Lymphoma; Leukemia, Myeloid, Acute; Myelodysplastic-Myeloproliferative Diseases
Details
  • Liste de produits
  • Informations sur les médicaments commercialisés
  • Informations sur les médicaments cliniques